Clinical Trial Update: A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety of a recombinant herpes zoster vaccine in healthy individuals. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Recombinant Herpes Zoster Vaccine

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Herpes Zoster (HZ) | Phase 1, Phase 2 | Status: RECRUITING